Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia
Proceedings of the National Academy of Sciences · 18.02.2025 · 122 (7)
DOI: 10.1073/pnas.2423169122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 13.02.2025. Verfasst von Jun-Yu Wang und 33 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Research…. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Gene Expression Regulation, Leukemic, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), State Key Laboratory of Medical Genomics, 111 Plan | Overseas Expertise Introduction Project for Discipline Innovation.
Abstract (Originalsprache)
Acute lymphoblastic leukemia (ALL) poses challenges in adult patients, considering its heterogeneous nature and often suboptimal treatment outcomes. Here, we performed a study on 201 newly diagnosed adult ALL cases (age ≥ 15 y) to generate intracellular and dynamic serum metabolomic profiles. Our findings revealed a predominant increase in bile acid (BA) metabolites in serum, alongside metabolic rewiring that supported highly proliferative states and actively metabolic signaling, such as enriched nucleotide metabolism in leukemic blasts. By integrating intracellular metabolomics and transcriptomics, we constructed the Comprehensive Metabolic Information Dataset (CMID), which facilitated the development of a clustering system to supplement current risk stratification. Furthermore, we explored potential metabolic interventions targeting the serum BA profile and energy metabolism in blasts. The combined use of simvastatin with vincristine and dexamethasone regimen demonstrated a synergistic therapeutic effect in a murine ALL model, effectively lowering key BA levels in serum and suppressing the infiltration of leukemic blasts in the liver. In light of the enhanced intracellular redox metabolism, combining FK866 (a nicotinamide phosphoribosyltransferase inhibitor) and venetoclax significantly prolonged survival in a patient-derived xenograft ALL model. Our findings, along with the resulting resources ( http://www.genetictargets.com/MALL ), provide a framework for the metabolism-centered management of ALL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Research Unit of Hematologic Malignancies Genomics and Translational Research…
- Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
- School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200030, China.
- Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
- Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
ORCID-Profile: Jun-Yu Wang, Xiang-Qin Weng, Yu-Ting Dai, Zhen-Yi Wang, Sheng-Yue Wang, Jian-Qing Mi, Zhu Chen, Wen-Lian Chen, Hai Fang, Sai-Juan Chen
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- State Key Laboratory of Medical Genomics
- 111 Plan | Overseas Expertise Introduction Project for Discipline Innovation
- Innovative Research Team of High-level Local Universities in Shanghai
- Shanghai Guangci Translational Medical Research Development Foundation
- Samuel Waxman Cancer Research Foundation (SWCRF)
- CAMS Innovation Fund for Medical Sciences
- Science and Technology Commission of Shanghai Municipality (STCSM)
Zitieren
APA
Wang, J. Y., Gui, T. T., Jiao, B., Liu, X., Ma, X. L., Wang, C., Qiao, J., Liu, W. Y., Peng, L. J., Ren, J. Y., Zhu, Y. M., Weng, X. Q., Wang, C., Zhang, Q. Q., Song, G. X., Dai, Y. T., Wang, Z. Y., Lv, G., Gao, C. X., …, & Chen, S. J. (2025). Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences, 122(7). https://doi.org/10.1073/pnas.2423169122
Vancouver
Wang JY, Gui TT, Jiao B, Liu X, Ma XL, Wang C, et al. Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences. 2025;122(7). doi:10.1073/pnas.2423169122
BibTeX
@article{Wang2025,
author = {Wang, Jun-Yu and Gui, Tuan-Tuan and Jiao, Bo and Liu, Xuan and Ma, Xiao-Lin and Wang, Cheng and Qiao, Jing and Liu, Wei-Yang and Peng, Li-Jun and Ren, Jia-Yi and Zhu, Yong-Mei and Weng, Xiang-Qin and Wang, Chao and Zhang, Qian-Qian and Song, Gao-Xian and Dai, Yu-Ting and Wang, Zhen-Yi and Lv, Gang and Gao, Chen-Xu and Qiao, Niu and Zhang, Ming and Tan, Yun and Liu, Yuan-Fang and Wang, Sheng-Yue and Hou, Jian and Jing, Duo-Hui and Lyu, An-Kang and Mi, Jian-Qing and Chen, Zhu and Chen, Wen-Lian and Yin, Tong and Fang, Hai and Wang, Jin and Chen, Sai-Juan},
title = {Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {7},
doi = {10.1073/pnas.2423169122}
}
EUVIMED